Pure Bioscience (PURE)
Add to Watchlists Create an AlertPURE Key Stats
| Income Statement | |
| Revenue TTM | 0.707M |
| Revenue Quarterly YoY Growth | 19.00% |
| EPS Diluted TTM | -1.139 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -8.314M |
| Profitability | |
| Gross Profit Margin Quarterly | 78.33% |
| Profit Margin Quarterly | -693.5% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | |
| Enterprise Value | |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.7457 |
| Free Cash Flow | |
| Return on Equity | -426.1% |
PURE News
- PURE Bioscience Appoints Dave Pfanzelter Chairman of the Board Marketwired May 17
- PURE Bioscience Stock to Begin Trading on the OTCQB Marketplace Marketwired May 17
- PURE BIOSCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Sati... May 17
- PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agree... Apr 29
- InPlay: PURE Bioscience receives favorable NASDAQ listing decision Apr 25
- PURE Bioscience Receives Favorable NASDAQ Listing Decision Benzinga Apr 25
- PURE BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and... Apr 25
- PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agree... Apr 23
- BioCryst (BCRX) Continues Higher on Latest Bird Flu Death Street Insider Apr 12
- Biotechs Ramping Up On China's Avian Flu Outbreak Apr 8
PURE Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pure Bioscience is down 83.70% over the last year vs S&P 500 Total Return up 27.77%, Air Products & Chemicals up 20.52%, and Airgas up 17.82%.
PURE Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these PURE related companies
Pro Ratings for PURE
Pro Report PDF for PURE
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Pro Strategies Featuring PURE
Did Pure Bioscience make it into our Pro Portfolio Strategies?
PURE Profile
Sector: Basic Materials
Industry: Chemicals
Other PURE Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PURE | 0.3652 | +0.00 | +0.00% |